Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)

NCT06434818 is registered in ClinicalTrials.gov with Evon Medics LLC as lead sponsor.

NCT NCT06434818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06434818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)
Lead sponsor
Evon Medics LLC
Phase
Phase 2
Overall status
Unknown status
Start date
July 7, 2023
Completion date
June 30, 2025
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, cocaine use disorder, methamphetamine-dependence, opioid use disorder, substance use disorders